2055840-70-3 (2,6-Naphthyridine, 8-bromo-1,2,3,4-tetrahydro-, hydrochloride (1:2),8-Bromo-1,2,3,4-tetrahydro-2,6-naphthyridine dihydrochloride)

快速询单

结构式：

2,6-Naphthyridine, 8-bromo-1,2,3,4-tetrahydro-, hydrochloride (1:2)MOL文件

CAS号：

2055840-70-3

中文名称：

2,6-Naphthyridine, 8-bromo-1,2,3,4-tetrahydro-, hydrochloride (1:2)

英文名称：

8-Bromo-1,2,3,4-tetrahydro-2,6-naphthyridine dihydrochloride

分子式：

C₈H₁₁BrCl₂N₂

分子量：

285.996339082718

2,6-Naphthyridine, 8-bromo-1,2,3,4-tetrahydro-, hydrochloride (1:2)(2055840-70-3)名称与标识符

名称

英文别名：

8-Bromo-1,2,3,4-tetrahydro-2,6-naphthyridine dihydrochloride;8-Bromo-1,2,3,4-tetrahydro-2,6-naphthyridine 2HCl;8-bromo-1,2,3,4-tetrahydro-2,6-naphthyridine;dihydrochloride;P16622;2055840-70-3;8-Bromo-1,2,3,4-tetrahydro-2,6-naphthyridinedihydrochloride;AS-53527;2,6-Naphthyridine, 8-bromo-1,2,3,4-tetrahydro-, hydrochloride (1:2);CS-0049966;AKOS030630897;

标识符

MDL：

MFCD30531322

InChIKey：

SMPLYJFPRQXJMJ-UHFFFAOYSA-N

Inchi：

1S/C8H9BrN2.2ClH/c9-8-5-11-3-6-1-2-10-4-7(6)8;;/h3,5,10H,1-2,4H2;2*1H

SMILES：

BrC1=CN=CC2=C1CNCC2.Cl.Cl

2,6-Naphthyridine, 8-bromo-1,2,3,4-tetrahydro-, hydrochloride (1:2)(2055840-70-3)物化性质

计算特性

精确分子量 : 283.94827g/mol
氢键供体数量 : 3
氢键受体数量 : 2
可旋转化学键数量 : 0
同位素质量 : 283.94827g/mol
重原子数量 : 13
复杂度 : 140
同位素原子数量 : 0
确定原子立构中心数量 : 0
不确定原子立构中心数量 : 0
确定化学键立构中心数量 : 0
不确定化学键立构中心数量 : 0
共价键单元数量 : 3
拓扑分子极性表面积 : 24.9

2,6-Naphthyridine, 8-bromo-1,2,3,4-tetrahydro-, hydrochloride (1:2)(2055840-70-3)推荐厂家更多厂家(4)

公司名称	手机号/电话	联系人	QQ	询单
上海瀚思化工有限公司	18939883912 021-34536277	顾经理	3003949364	询单
江苏艾康生物医药研发有限公司	18795912720 025-66061636	杨情情	3004779232	询单
上海阿拉丁生化科技股份有限公司	13167063860 13167063860	阿拉丁	3004013043	询单
上海阿拉丁生化科技股份有限公司	13167063860 13167063860	阿拉丁	3004013043	询单

2,6-Naphthyridine, 8-bromo-1,2,3,4-tetrahydro-, hydrochloride (1:2)(2055840-70-3)相关文献

1. Experimental and theoretical second harmonic generation and photoluminescence from the pseudo-centrosymmetric dihydrochloride salt dihydrate of trans-1,2-bis(4-pyridyl)ethene
Ana Karoline Silva Mendanha Valdo,Cameron Capeletti da Silva,Lauro June Queiroz Maia,Ariel M. Sarotti,Felipe T. Martins CrystEngComm 2017 19 346
2. Screening and RSM optimization for synthesis of a Gum tragacanth–acrylic acid based device for in situ controlled cetirizine dihydrochloride release
B. S. Kaith,Saruchi,Rajeev Jindal,Manpreet S. Bhatti Soft Matter 2012 8 2286
3. Capturing a new hydrate polymorph of amodiaquine dihydrochloride dihydrate via heterogeneous crystallisation
Okky Dwichandra Putra,Anna Pettersen,Sten O. Nilsson Lill,Daiki Umeda,Etsuo Yonemochi,Yuda Prasetya Nugraha,Hidehiro Uekusa CrystEngComm 2019 21 2053
4. Design, synthesis, and solution behaviour of small polyamines as switchable water additives
Sean M. Mercer,Tobias Robert,Daniel V. Dixon,Chien-Shun Chen,Zahra Ghoshouni,Jitendra R. Harjani,Soran Jahangiri,Gilles H. Peslherbe,Philip G. Jessop Green Chem. 2012 14 832
5. Ring-opening reactions of 1,4-diazabicyclo[2.2.2]octane (DABCO) derived quaternary ammonium salts with phenols and related nucleophiles
Nenad Mara?,Slovenko Polanc,Marijan Ko?evar Org. Biomol. Chem. 2012 10 1300
6. Recent advances in the synthesis of benzimidazol(on)es via rearrangements of quinoxalin(on)es
Vakhid A. Mamedov RSC Adv. 2016 6 42132
7. Reductive exfoliation of substoichiometric MoS2 bilayers using hydrazine salts
Torben Daeneke,Rhiannon M. Clark,Benjamin J. Carey,Jian Zhen Ou,Bent Weber,Michael S. Fuhrer,Madhu Bhaskaran,Kourosh Kalantar-zadeh Nanoscale 2016 8 15252
8. Drug-likeness of linear pentamidine analogues and their impact on the hERG K+ channel – correlation with structural features
Teresa ?o?ek,Muge Qile,Pawe? Ka?mierczak,Meye Bloothooft,Marcel A. G. van der Heyden,Dorota Maciejewska RSC Adv. 2019 9 38355
9. Development of prospective non-toxic inhibitors of ABCB1 activity and expression in a series of selenophenoquinolinones
Jelena Vasiljeva,Marina Makrecka-Kuka,Ilona Domracheva,Karlis Vilks,Pavels Dimitrijevs,Pavel Arsenyan New J. Chem. 2022 46 7424
10. Design, synthesis, and in vitro and in vivo characterization of 1-{4-[4-(substituted)piperazin-1-yl]butyl}guanidines and their piperidine analogues as histamine H3 receptor antagonists
Marek Staszewski,Anna Stasiak,Tadeusz Karcz,Daniel McNaught Flores,Wies?awa Agnieszka Fogel,Katarzyna Kie?-Kononowicz,Rob Leurs,Krzysztof Walczyński Med. Chem. Commun. 2019 10 234

801-72-9(5,6-Epoxy-5,6-dihydroretinol acetate) 801303-33-3(N-甲氧基-N-甲基4-溴-2-氟苯甲酰胺) 801992-53-0(2,3-DIHYDRO-6,N-DIMETHYL-1H-INDEN-1-AMINE) 79516-59-9((S)-3-羟基戊酸) 79600-87-6(4-phenyl-1H-pyrrole-2-carboxylic acid) 8015-96-1(肉桂油) 80240-38-6(4-(3-氯苯基)-2,4-二氢-3H-1,2,4-三唑-3-酮) 80235-10-5(2-羟基-4-(羟基甲基)苯甲酸甲酯)

960化工网为您提供2,6-Naphthyridine, 8-bromo-1,2,3,4-tetrahydro-, hydrochloride (1:2)专业化合物百科信息，包括中文名，英文名，分子式，分子量，以及该化合物的CasNo.2055840-70-3,相关理化性质;并提供了优质生产厂家信息包括厂家名称和联系方式等。 WAP版:2055840-70-3 国际站:2055840-70-3